SCHEMBL6045219

SCHEMBL6045219

CP(=O)(O)O[C@@H](CC=O)[C@H](O)CO.OP(O)(O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6045389 0.95 MPI (0.31)
SCHEMBL4066409 0.83
SCHEMBL139867 0.81 PTPN1 (0.38)
SCHEMBL6429913 0.81 PTPN1 (0.38)
SCHEMBL10380111 0.79 PTPN1 (0.32)
SCHEMBL15127430 0.79 MPI (0.33)
SCHEMBL7104411 0.75 BTN3A1 (0.39)
SCHEMBL320909 0.73 BTN3A1 (0.37)
SCHEMBL27743391 0.73 AKR1B1 (0.33)
SCHEMBL199123 0.73 AKR1B1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060183886-A1 Ligands to enhance cellular uptake of biomolecules CELL WORKS THERAPEUTICS, INC., A DELAWARE CORPORATION 2006-08-17 US claimed
EP-1409548-A4 LIGANDS TO ENHANCE CELLULAR UPTAKE OF BIOMOLECULES CELL WORKS THERAPEUTICS INC (US) 2005-08-31 EP claimed
EP-1409548-A2 LIGANDS TO ENHANCE CELLULAR UPTAKE OF BIOMOLECULES Cell Works Inc. (US) 2004-04-21 EP claimed
WO-2003067209-A2 LIGANDS TO ENHANCE CELLULAR UPTAKE OF BIOMOLECULES CELL WORKS INC. (US) 2003-08-14 WO claimed
US-20030119724-A1 Ligands to enhance cellular uptake of biomolecules NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-06-26 US claimed